bioRxiv Science⌕ Search

Biology subjects

Parsons, S.

Publications and source records attributed to Parsons, S..

7 recordsLinked to original sources

A patient derived xenograft repository capturing clinical and molecular heterogeneity of large B-cell lymphoma

Large B-cell lymphomas (LBCLs) are a clinically and molecularly diverse group of malignancies with a rapidly evolving therapeutic landscape that has introduced new areas of clinical need such as post-CD19 chimeric antigen receptor T (CART19) progression. Patient derived xenograft (PDX) models are an important tool for mechanistic studies and preclinical evaluation of new therapies and can be generated from a variety of clinical contexts that capture tumor-intrinsic resistance mechanisms. We therefore undertook a comprehensive effort to generate PDX models that encompass the molecular landscape of LBCLs and include important clinical scenarios for new drug development. Here we describe the first 48 models within this publicly available repository, capturing the transcriptional and genetic subsets of LBCL. These models also include 23 generated from post-CART progression biopsies which reproduce patterns of progression driven by CD19 mutation or expression loss, as well as tumor cell-intrinsic CART19 resistance that we validate in vivo. STATEMENT OF SIGNIFICANCEYang et al. describe X-LYMPH (Xenografts of Lymphoma), a publicly available and molecularly annotated PDX repository that captures the heterogeneity of large B-cell lymphoma. X-LYMPH includes models of chimeric antigen receptor T cell resistance, providing a shared foundation for mechanistic research and therapeutic development for lymphomas.

cancer biology↗

mTOR signaling controls the formation of smooth muscle cell-derived intimal fibroblasts during vasculitis.

The excessive accumulation of fibroblasts within the intimal layer of inflamed vessels is a feared complication of vasculitis, which can lead to arterial stenosis and ischemia. In this study, we have investigated how such intimal fibroblasts develop during Kawasaki Disease (KD), a paediatric vasculitis typically involving the coronary arteries. By performing lineage tracing studies in a murine model of KD, we reveal that vasculitis-induced intimal fibroblasts develop independently of both adventitial fibroblasts and endothelial cells, and instead derive from smooth muscle cells (SMCs). Notably, the emergence of SMC-derived intimal fibroblasts - in both mice and in patients with KD, Takayasus arteritis and Giant Cell arteritis - coincided with their activation of the mechanistic target of rapamycin (mTOR) signalling pathway. Moreover, the genetic deletion of mTOR signalling in SMCs abrogated the emergence of intimal fibroblasts, demonstrating that mTOR is an intrinsic and essential regulator of vasculitis-induced, SMC-derived intimal fibroblasts. Collectively these findings provide molecular insight into the pathogenesis of arterial stenosis and identify mTOR as a therapeutic target to prevent adverse vascular remodelling in vasculitis.

cell biology↗

CREBBP lysine acetyltransferase domain mutations create zombie enzymes that alter chromatin loading dynamics and prevent EP300 redundancy

Epigenetic regulation of gene expression is fundamental to cell state transitions. A prominent example of this is the epigenetically-regulated generation of transitory cells states within the germinal center (GC) reaction that are required for humoral immunity. The deregulation of these processes through somatic mutations can give rise to B-cell lymphoma, thus studying these mutations can provide insight into fundamental mechanisms underlying epigenetic regulation of gene expression as well as GC B-cell and lymphoma biology. Here we show that classes of mutations in the CREBBP lysine acetyltransferase gene result in different structure, catalytic activity and function. We discover that CREBBP and its paralog EP300 are dynamically and reciprocally loaded onto chromatin during a signal-responsive cell state transitions within the GC. Mutation of CREBBP in GC-derived lymphoma interrupt signal-responsive CREBBP loading onto chromatin, while also inhibiting EP300 redundancy. These observations lead to a model in which CREBBP or EP300 loss of function through acetyltransferase domain mutations, which occur frequently in both hematopoietic and solid tumors, create a zombie enzyme that retards the function of the active paralog by binding limiting concentrations of transcription factor substrate and preventing signal-responsive enhancer activation.

cancer biology↗

Towards a General Approach for Bat Echolocation Detection and Classification

O_LIAcoustic monitoring is a scalable approach for assessing bat populations, yet automating the detection and classification of bat echolocation calls remains challenging, particularly in data-scarce regions. Although deep learning (DL) is increasingly applied to this task, most existing approaches repurpose computer-vision architectures and generate a single prediction per spectrogram clip, offering limited robustness to variable background noise and potentially constraining generality across regions and species assemblages. C_LIO_LIHere, we develop BatDetect2, an open-source DL pipeline for the joint detection and classification of bat echolocation calls. BatDetect2 builds on a 2D convolutional architecture and incorporates two targeted modifications: (i) a temporal self-attention layer designed to capture long-range structure across call sequences, and (ii) convolutional layers augmented with frequency coordinates to explicitly encode frequency information directly. We evaluate model generality using five diverse datasets from four different regions: UK, Mexico, Australia, and Brazil, and conduct ablation analyses using a UK dataset spanning 17 bat species. We further assess whether a trained model can detect echolocation calls from species absent from the training data. C_LIO_LIBatDetect2 consistently outperforms a traditional call-parameter extraction baseline across all datasets and evaluation metrics. Ablation analyses show that the inclusion of temporal self-attention yields a substantial species classification performance gain, increasing mean Average Precision (mAP) from 0.83 to 0.88, while frequency-coordinate augmentation provides no measurable benefit. When applied to novel species assemblages without retraining, model detection performance varies across datasets, with Average Precision ranging from 0.60 to 0.98. C_LIO_LIOverall, BatDetect2 demonstrates strong and transferable performance across acoustically and taxonomically diverse regions. By jointly detecting and classifying all bat calls present in each input clip, the pipeline provides a practical and extensible tool for passive acoustic monitoring. The full training pipeline and a pretrained UK model are released through the open-source Python package batdetect2, enabling practitioners to develop and deploy models using their own data. C_LI

ecology↗

Monoclonal antibody stability can be usefully monitored using the excitation-energy-dependent fluorescence edge-shift

Among the major challenges in the development of biopharmaceuticals are structural heterogeneity and aggregation. The development of a successful therapeutic monoclonal antibody (mAb) requires both a highly active and also stable molecule. Whilst a range of experimental (biophysical) approaches exist to track changes in stability of proteins, routine prediction of stability remains challenging. The fluorescence red edge excitation shift (REES) phenomenon is sensitive to a range of changes in protein structure. Based on recent work, we have found that quantifying the REES effect is extremely sensitive to changes in protein conformational state and dynamics. Given the extreme sensitivity, potentially this tool could provide a fingerprint of the structure and stability of a protein. Such a tool would be useful in the discovery and development of biopharamceuticals and so we have explored our hypothesis with a panel of therapeutic mAbs. We demonstrate that the quantified REES data show remarkable sensitivity, being able to discern between structurally identical antibodies and showing sensitivity to unfolding and aggregation. The approach works across a broad concentration range (g-mg/ml) and is highly consistent. We show that the approach can be applied alongside traditional characterisation testing within the context of a forced degradation study (FDS). Most importantly, we demonstrate the approach is able to predict the stability of mAbs both in the short (hours), medium (days) and long-term (months). The quantified REES data will find immediate use in the biopharmaceutical industry in quality assurance, formulation and development. The approach benefits from low technical complexity, is rapid and uses instrumentation which exists in most biochemistry laboratories without modification.

biochemistry↗

The genomic landscape of intrinsic and acquired resistance to cyclin-dependent kinase 4/6 inhibitors in patients with hormone receptor positive metastatic breast cancer

Clinical resistance mechanisms to CDK4/6 inhibitors in HR+ breast cancer have not been clearly defined. Whole exome sequencing of 59 tumors with CDK4/6i exposure revealed multiple candidate resistance mechanisms including RB1 loss, activating alterations in AKT1, RAS, AURKA, CCNE2, ERBB2, and FGFR2, and loss of ER expression. In vitro experiments confirmed that these alterations conferred CDK4/6i resistance. Cancer cells cultured to resistance with CDK4/6i also acquired RB1, KRAS, AURKA, or CCNE2 alterations, which conferred sensitivity to AURKA, ERK, or CHEK1 inhibition. Besides inactivation of RB1, which accounts for [~]5% of resistance, seven of these mechanisms have not been previously identified as clinical mediators of resistance to CDK4/6 inhibitors in patients. Three of these--RAS activation, AKT activation, and AURKA activation--have not to our knowledge been previously demonstrated preclinically. Together, these eight mechanisms were present in 80% of resistant tumors profiled and may define therapeutic opportunities in patients. SignificanceWe identified eight distinct mechanisms of resistance to CDK4/6 inhibitors present in 80% of resistant tumors profiled. Most of these have a therapeutic strategy to overcome or prevent resistance in these tumors. Taken together, these findings have critical implications related to the potential utility of precision-based approaches to overcome resistance in many patients with HR+ MBC.

cancer biology↗

Bat Detective - Deep Learning Tools for Bat Acoustic Signal Detection

O_LIPassive acoustic sensing has emerged as a powerful tool for quantifying anthropogenic impacts on biodiversity, especially for echolocating bat species. To better assess bat population trends there is a critical need for accurate, reliable, and open source tools that allow the detection and classification of bat calls in large collections of audio recordings. The majority of existing tools are commercial or have focused on the species classification task, neglecting the important problem of first localizing echolocation calls in audio which is particularly problematic in noisy recordings.\nC_LIO_LIWe developed a convolutional neural network (CNN) based open-source pipeline for detecting ultrasonic, full-spectrum, search-phase calls produced by echolocating bats (BatDetect). Our deep learning algorithms (CNN FULL and CNN FAST) were trained on full-spectrum ultrasonic audio collected along road-transects across Romania and Bulgaria by citizen scientists as part of the iBats programme and labelled by users of www.batdetective.org. We compared the performance of our system to other algorithms and commercial systems on expert verified test datasets recorded from different sensors and countries. As an example application, we ran our detection pipeline on iBats monitoring data collected over five years from Jersey (UK), and compared results to a widely-used commercial system.\nC_LIO_LIHere, we show that both CNNFULL and CNNFAST deep learning algorithms have a higher detection performance (average precision, and recall) of search-phase echolocation calls with our test sets, when compared to other existing algorithms and commercial systems tested. Precision scores for commercial systems were reasonably good across all test datasets (>0.7), but this was at the expense of recall rates. In particular, our deep learning approaches were better at detecting calls in road-transect data, which contained more noisy recordings. Our comparison of CNNFULL and CNNFAST algorithms was favourable, although CNNFAST had a slightly poorer performance, displaying a trade-off between speed and accuracy. Our example monitoring application demonstrated that our open-source, fully automatic, BatDetect CNNFAST pipeline does as well or better compared to a commercial system with manual verification previously used to analyse monitoring data.\nC_LIO_LIWe show that it is possible to both accurately and automatically detect bat search-phase echolocation calls, particularly from noisy audio recordings. Our detection pipeline enables the automatic detection and monitoring of bat populations, and further facilitates their use as indicator species on a large scale, particularly when combined with automatic species identification. We release our system and datasets to encourage future progress and transparency.\nC_LI

ecology↗